- Specialization
- Scientific Discovery
- Business
Software Applicationsand 1 more business valuesLess
- Model Development
- Market
Manufacturingand 2 more market valuesLess
- Agriculture
- Life Sciences
- Ecosystem
- AI for science
- Customers
Enterprisesand 1 more customers valuesLess
- Researchers
More details
- Organization type
- Commercial Company
- Ecosystem
- AI for science
- Business
- Software Applications, Model Development
- Specialization
- Scientific Discovery
- Market
- Manufacturing, Agriculture, Life Sciences
- Customers
- Enterprises, Researchers
- Delivery models
- Hosted Software
- Revenue models
- Not classified
- Listing status
- Not classified
- Latest equity round
- Seed
- Reported funding amount
- Not classified
About
Yoneda Labs builds AI software for chemists that predicts and optimizes reaction conditions such as temperature, concentration, and catalysts. It sells to organizations across agriculture, pharmaceuticals, and chemical manufacturing, differentiating itself through experimentally generated laboratory data, proprietary models, and tools designed for practical use in sensitive chemistry workflows.
Market
Yoneda Labs competes in AI-enabled chemistry R&D and chemical reaction/process optimization, spanning drug discovery, organic synthesis, and chemical manufacturing. Its positioning combines chemist-accessible software with experimentally generated wet-lab data: Yoneda Predict targets reliable conditions for novel reactions, while Yoneda Optimize searches for improved process conditions. This differentiates it from adjacent platforms such as Atinary’s Bayesian/agentic self-driving-lab software and ReactWise’s AI process-optimization copilot through its emphasis on its own reaction dataset and specialized prediction-plus-optimization workflow.
Pharmaceutical and chemical-manufacturing organizations—including Big Pharma and industrial chemistry companies—with agriculture and other industrial sectors also in scope. The primary users and buyers are synthetic chemists, process chemists, and R&D/process-development teams seeking to predict reaction conditions or optimize yield, cost, and environmental impact.
At a Glance
Problem
Yoneda Labs addresses the slow, expensive, and error-prone process of optimizing chemical reactions. When chemists develop a drug or material, they often have to search the literature and run trial-and-error experiments to determine parameters such as temperature, concentration, catalyst, and other conditions. The company says chemists can spend weeks guessing at those conditions, while existing machine-learning tools often generalize poorly or require programming expertise.
The main use case is accelerating reaction and process development, especially difficult synthesis steps such as transition-metal-catalyzed cross-coupling. Poorly chosen conditions mean wasted experiments, lower yields, excess labor, delayed drug or material development, and potentially delayed market exclusivity. In a 2025 Symeres collaboration, Yoneda’s software helped improve yields from roughly 30% to above 90%, illustrating the economic value of finding high-yielding conditions with fewer experimental iterations.
Product / Service
Yoneda provides AI-enabled chemistry software, centered on the Yoneda Optimize application, to predict and optimize reaction conditions. The app learns from a chemist’s experimental data, uses predictive modeling to recommend iterative experiments, and is designed to make advanced statistics and machine learning accessible through a few clicks. Yoneda says its broader foundation model is being trained on tens of thousands of experimentally generated data points, while funding has also supported robotic automation for generating and analyzing additional reactions.
The delivery model is software for laboratory and process-development teams, supported by demonstrations and industry collaborations, with custom algorithms that can run offline on a chemist’s PC for sensitive data. The stated benefit is to find optimal process conditions in days rather than months, increase chemist capacity, maximize yield while reducing cost and environmental impact, and automate adjacent analytical work such as LCMS interpretation. Yoneda claims its software doubles chemists’ efficiency; its LCMS tool is described as saving five minutes per chromatogram, or about eight hours per 96-well plate.
Market
Yoneda competes in the emerging market for AI-enabled chemical reaction optimization, computational chemistry, and software-assisted chemical process development. ReactWise is a close comparable, positioning itself as an AI copilot for chemical process optimization. Broader or more adjacent competitors include Citrine Informatics, which applies AI through a SaaS platform for materials and chemicals development, and Chemify, which combines chemistry AI with robotics to design, discover, and make molecules. These companies overlap with Yoneda in using data and automation to shorten chemical development cycles, although their levels of software, robotics, and discovery coverage differ.
Yoneda is not supported by the available evidence as a pre-revenue company. It was founded in 2023, participated in Y Combinator’s Winter 2024 batch, and raised at least $4 million in seed capital from Khosla Ventures, 500 Emerging Europe, 468 Capital, and Y Combinator to build its foundation model and automated laboratory capability. The company says it is used across industries including agriculture, big pharma, and chemical manufacturing, and its 2025 Symeres collaboration provides named commercial validation. A secondary estimate put 2024 revenue at $1.1 million, but Yoneda has not publicly disclosed customer counts, recurring revenue, or broader scale in the evidence reviewed.
Founders & Leadership
Funding History
Y Combinator
Khosla Ventures
Active Roles
0No active roles right now.
Get notified when they postBusiness Model
Yoneda Labs appears to operate as a demo-led B2B software company, offering AI tools for reaction prediction, process optimization, and chemical-data analysis to industrial customers. Its website directs prospective customers to personalized demos; public pricing and exact contract terms were not disclosed in the available evidence.